Transplant Patient Registry of Liver, Kidney and/or Pancreas

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Virginia Commonwealth University
Sponsor:
Information provided by (Responsible Party):
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT00238693
First received: October 11, 2005
Last updated: May 14, 2014
Last verified: May 2014
  Purpose

This is a registry of data collected from patient records, both of those who have a condition which may require transplantation and those who have undergone transplantation of the liver, kidney and/or pancreas.


Condition
Hepatitis B
Hepatitis C
Liver Cirrhosis
Hepatocellular Carcinoma
Polycystic Kidney Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Transplant Registry: Patients Who May Require Transplantation and Those Who Have Undergone Transplantation of Liver, Kidney and/or Pancreas

Resource links provided by NLM:


Further study details as provided by Virginia Commonwealth University:

Primary Outcome Measures:
  • Data collection and maintenance [ Time Frame: Ongoing ] [ Designated as safety issue: No ]
    MAINTAIN A CURRENT, ACCURATE DATA BASE OF TRANSPLANT RECIPIENTS WITH REGARDS TO TRANSPLANT DATA AND OUTCOMES.


Estimated Enrollment: 2000
Study Start Date: April 2003
Estimated Study Completion Date: January 2025
Estimated Primary Completion Date: January 2025 (Final data collection date for primary outcome measure)
Detailed Description:

With consent from the patient, a systematic review of the patient's medical record takes place and data is entered into a secure database. Risk to the patient is negligible compared to the possible benefit to patients from the analysis of data.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients followed in the transplant clinic at Virginia Commonwealth University Health System

Criteria

Inclusion Criteria:

  • Patients followed in the transplant clinic at Virginia Commonwealth University Health System
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00238693

Contacts
Contact: Robert A Fisher, MD 804-828-2461
Contact: Mary Baldecchi, RN 804-828-7925

Locations
United States, Virginia
Virginia Commonwealth University Health System Recruiting
Richmond, Virginia, United States, 23298
Contact: Robert A Fisher, MD    804-828-2461      
Sponsors and Collaborators
Virginia Commonwealth University
Investigators
Principal Investigator: Robert A Fisher, MD, FACS Virginia Commonwealth University Health System
  More Information

No publications provided

Responsible Party: Virginia Commonwealth University
ClinicalTrials.gov Identifier: NCT00238693     History of Changes
Other Study ID Numbers: VCU3127
Study First Received: October 11, 2005
Last Updated: May 14, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Virginia Commonwealth University:
transplant
transplantation of liver, kidney, pancreas

Additional relevant MeSH terms:
Polycystic Kidney Diseases
Hepatitis
Hepatitis A
Hepatitis C
Kidney Diseases
Hepatitis B
Carcinoma, Hepatocellular
Liver Cirrhosis
Multicystic Dysplastic Kidney
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections
Urologic Diseases
Hepadnaviridae Infections
DNA Virus Infections
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Kidney Diseases, Cystic
Urogenital Abnormalities

ClinicalTrials.gov processed this record on October 01, 2014